Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, w...
Q1 2026
May 7, 2026
FY 2025
Mar 19, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 6, 2025